Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction.
Saved in:
| Title: | Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction. |
|---|---|
| Authors: | Novitskaya T; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Nishat S; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio., Covarrubias R; Division of Cardiac Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Davis Heart and Lung Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio., Wheeler DG; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Chepurko E; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Bermeo-Blanco O; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Xu Z; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Baer B; Department of Mechanical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee., He H; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Moore SN; Division of Orthopedic Surgery, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Dwyer KM; Immunology Research Center, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia., Cowan PJ; Immunology Research Center, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia., Su YR; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Absi TS; Division of Cardiac Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee., Schoenecker J; Division of Orthopedic Surgery, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee., Bellan LM; Department of Mechanical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee., Koch WJ; Temple University, Philadelphia, Pennsylvania., Bansal S; Davis Heart and Lung Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio., Feoktistov I; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Robson SC; Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Gao E; Temple University, Philadelphia, Pennsylvania., Gumina RJ; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Davis Heart and Lung Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio. |
| Source: | American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2022 Dec 01; Vol. 323 (6), pp. H1244-H1261. Date of Electronic Publication: 2022 Oct 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1539 (Electronic) Linking ISSN: 03636135 NLM ISO Abbreviation: Am J Physiol Heart Circ Physiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
